Cargando…
Danlou tablet inhibits high-glucose-induced cardiomyocyte apoptosis via the miR-34a-SIRT1 axis
Diabetic cardiomyopathy (DCM) is highly prevalent and increases the risk of heart failure and sudden death. Therefore, proper and effective treatments for DCM are in urgent demand. Danlou tablet (Dan) is reported to confer protective effects on several heart diseases. However, to our knowledge, whet...
Autores principales: | Chen, Rui, Chen, Hongjian, Yang, Zijiang, Zhu, Liyun, Bei, Yihua, Chen, Wei, Qiu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025156/ https://www.ncbi.nlm.nih.gov/pubmed/36950610 http://dx.doi.org/10.1016/j.heliyon.2023.e14479 |
Ejemplares similares
-
PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury
por: Wei, Meng, et al.
Publicado: (2022) -
Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis
por: Mao, WeiLi, et al.
Publicado: (2023) -
Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
por: Liu, Chunping, et al.
Publicado: (2021) -
Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial
por: Yang, Guang, et al.
Publicado: (2020) -
Danlou Tablet Activates Autophagy of Vascular Adventitial Fibroblasts Through PI3K/Akt/mTOR to Protect Cells From Damage Caused by Atherosclerosis
por: Wang, Li, et al.
Publicado: (2021)